View all reports
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events
2024. 06. 12
New C2H Report: Tezepelumab (Tezspire)
2024. 04. 28
New C2H Report: Deucravacitinib (Sotyktu)
2024. 03. 13
New C2H Report: Molnupiravir (Lagevrio)
View all news